We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+10.92%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$43.9B
AUM Growth
+$2.87B
(+7%)
Cap. Flow
-$890M
Cap. Flow
% of AUM
-2.03%
Top 10 Holdings %
Top 10 Hldgs %
13.25%
Holding
2,343
New
170
Increased
997
Reduced
1,015
Closed
150
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$111M |
| 2 |
Verizon
VZ
|
+$103M |
| 3 |
AT&T
T
|
+$103M |
| 4 |
Kroger
KR
|
+$97.1M |
| 5 |
3M
MMM
|
+$92.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$138M |
| 2 |
Tesla
TSLA
|
+$110M |
| 3 |
JPMorgan Chase
JPM
|
+$103M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$89.4M |
| 5 |
Apple
AAPL
|
+$85.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 16.25% |
| 3 | Financials | 11.85% |
| 4 | Industrials | 11.44% |
| 5 | Consumer Discretionary | 10.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
51
Colgate-Palmolive
CL
$74.4B
| $159M | 0.36% |
2,013,180
+115,505
| +6% | +$8.66M |
|
|
52
Humana
HUM
$46.2B
| $153M | 0.35% |
301,239
+211,589
| +236% | +$111M |
|
53
Owens Corning
OC
$12.4B
| $152M | 0.35% |
1,785,654
-16,576
| -0.9% | -$1.45M |
|
54
Hewlett Packard
HPE
$70.5B
| $152M | 0.35% |
9,586,843
+3,298,626
| +52% | +$48.6M |
|
55
Elevance Health
ELV
$85.5B
| $146M | 0.33% |
286,432
-19,998
| -7% | -$10.2M |
|
|
WRK
56
DELISTED
WestRock Company
WRK
| $145M | 0.33% |
4,139,825
+315,701
| +8% | +$11M |
|
57
Travelers Companies
TRV
$80.2B
| $145M | 0.33% |
772,805
+52,653
| +7% | +$9.47M |
|
58
Eli Lilly
LLY
$1.06T
| $138M | 0.31% |
376,325
-106,760
| -22% | -$37.9M |
|
59
ConocoPhillips
COP
$141B
| $137M | 0.31% |
1,177,398
-648,097
| -36% | -$78.8M |
|
60
Medtronic
MDT
$112B
| $136M | 0.31% |
1,758,335
+567,674
| +48% | +$46M |
|
61
Textron
TXT
$15.4B
| $133M | 0.3% |
1,882,665
-84,704
| -4% | -$5.75M |
|
62
The Mosaic Company
MOS
$7.33B
| $133M | 0.3% |
3,060,014
+969,278
| +46% | +$48M |
|
63
Lockheed Martin
LMT
$136B
| $132M | 0.3% |
271,813
+19,875
| +8% | +$9.24M |
|
64
Everest Group
EG
$14.4B
| $132M | 0.3% |
397,953
-121,042
| -23% | -$37.7M |
|
65
Cognizant
CTSH
$26B
| $130M | 0.3% |
2,301,287
+585,978
| +34% | +$34.4M |
|
66
Home Depot
HD
$355B
| $129M | 0.29% |
409,609
-241,468
| -37% | -$73.6M |
|
67
Pultegroup
PHM
$25.3B
| $129M | 0.29% |
2,839,688
-881,106
| -24% | -$37.1M |
|
68
Viatris
VTRS
$18.9B
| $125M | 0.29% |
11,367,501
+854,820
| +8% | +$8.93M |
|
69
Booking.com
BKNG
$161B
| $124M | 0.28% |
1,554,000
-515,400
| -25% | -$39.1M |
|
70
Builders FirstSource
BLDR
$8.04B
| $123M | 0.28% |
1,904,770
-32,905
| -2% | -$2.06M |
|
71
Snap-on
SNA
$21.5B
| $122M | 0.28% |
534,531
-57,792
| -10% | -$13.1M |
|
72
Robert Half
RHI
$4.37B
| $122M | 0.28% |
1,662,788
-348,835
| -17% | -$26.6M |
|
73
Public Storage
PSA
$61.3B
| $121M | 0.28% |
431,554
-145,906
| -25% | -$42.5M |
|
74
Archer Daniels Midland
ADM
$36.9B
| $120M | 0.27% |
1,295,189
+92,164
| +8% | +$8.51M |
|
75
Hershey
HSY
$36.6B
| $119M | 0.27% |
515,257
-69,030
| -12% | -$15.9M |
|
Similar funds
VGA
AQR Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, AQR Capital Management held 2,343 positions worth $43.9B, up 7% from $41B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2022 filing shows 170 new, 997 increased, 1,015 reduced and 150 closed positions. Its largest new stake was Generac Holdings: 310,080 shares worth $30.5M. The largest sale was Gilead Sciences, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q4 2022 buy was Generac Holdings: 310,080 shares worth $30.5M.
- AQR Capital Management added most to Humana in Q4 2022, an estimated $111M increase.
- AQR Capital Management's biggest Q4 2022 reduction was Gilead Sciences, cutting an estimated $138M.
- AQR Capital Management fully exited Abiomed Inc in Q4 2022, selling an estimated $22.4M.
- AQR Capital Management's ten largest holdings make up 13% of its $43.9B portfolio in Q4 2022.
- AQR Capital Management opened 170 new positions and closed 150 in Q4 2022.
- AQR Capital Management's portfolio value rose 7% quarter-over-quarter to $43.9B.
Based on AQR Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.